Back
Novo Nordisk AS Stock Price Chart

Former Zillow execs target $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
26
NVO
Novo Nordisk AS
Last Price:
$65.39
Seasonality Move:
4.73%
7 Day Trial
ALL ACCESS PASS
$
7

The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing buying pressure, which is a positive indicator for future bullish movement.
Novo Nordisk AS Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 67.02 | Buy |
20-day SMA: | 64.31 | Buy |
50-day SMA: | 70.43 | Sell |
200-day SMA: | 99.63 | Sell |
8-day EMA: | 66.39 | Buy |
20-day EMA: | 65.96 | Buy |
50-day EMA: | 70.31 | Sell |
200-day EMA: | 91.7 | Sell |
Novo Nordisk AS Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.51 | Sell |
Relative Strength Index (14 RSI): | 52.43 | Buy |
Chaikin Money Flow: | 18128168 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (61.14 - 67.06) | Buy |
Bollinger Bands (100): | (67.43 - 89.71) | Sell |
Novo Nordisk AS Technical Analysis
Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Novo Nordisk AS Stock
Is Novo Nordisk AS Stock a Buy?
-
Novo Nordisk AS share price is 67.74 while NVO 8-day simple moving average is 67.02, which is a Buy signal.
-
The stock price of NVO is 67.74 while Novo Nordisk AS 20-day SMA is 64.31, which makes it a Buy.
-
Novo Nordisk AS 50-day simple moving average is 70.43 while NVO share price is 67.74, making it a Sell technically.
-
NVO stock price is 67.74 and Novo Nordisk AS 200-day simple moving average is 99.63, creating a Sell signal.
NVO Technical Analysis vs Fundamental Analysis
Sell
26
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS a Buy or a Sell?
-
Novo Nordisk AS stock is rated a SellThe current Novo Nordisk AS [NVO] share price is $67.74. The Score for NVO is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
Novo Nordisk AS Stock Info
Market Cap:
301B
Price in USD:
67.74
Share Volume:
18.2M
Novo Nordisk AS 52-Week Range
52-Week High:
148.15
52-Week Low:
57.00
Sell
26
Novo Nordisk AS (NVO)
is a Sell
Novo Nordisk AS Share Price Forecast
-
What is the Novo Nordisk AS stock price today?The Novo Nordisk AS stock price is 67.74 USD today.
-
Will NVO stock go up or go down?Novo Nordisk AS> share price is forecast to RISE/FALL based on technical indicators
-
Is Novo Nordisk AS overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Novo Nordisk AS is overvalued.
Is Novo Nordisk AS Stock a Buy?
-
Novo Nordisk AS share price is 67.74 while NVO 8-day exponential moving average is 66.39, which is a Buy signal.
-
The stock price of NVO is 67.74 while Novo Nordisk AS 20-day EMA is 65.96, which makes it a Buy.
-
Novo Nordisk AS 50-day exponential moving average is 70.31 while NVO share price is 67.74, making it a Sell technically.
-
NVO stock price is 67.74 and Novo Nordisk AS 200-day simple moving average is 91.70, creating a Sell signal.
Fundamental Analysis of Novo Nordisk AS
Is Novo Nordisk AS a good investment?
-
Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.15 per share, an increase this year of $0.87 per share, and an increase next year of $0.74 per share.
Technical Analysis of Novo Nordisk AS
Should I short Novo Nordisk AS stock?
-
NVO Moving Average Covergence Divergence (MACD) indicator is -0.51, suggesting Novo Nordisk AS is a Sell
-
Novo Nordisk AS Relative Strength Index (RSI) is 52.43, which suggest Novo Nordisk AS is overbought
-
The Bollinger Bands (25) for Novo Nordisk AS is (61.14 - 67.06), which suggest Novo Nordisk AS is a Sell
-
The Bollinger Bands (100) for Novo Nordisk AS is (67.43 - 89.71), which suggest Novo Nordisk AS is a Sell
* Novo Nordisk AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.